Your browser doesn't support javascript.
loading
Hyperoxia prevents the dynamic neonatal increases in lung mesenchymal cell diversity.
Zanini, Fabio; Che, Xibing; Suresh, Nina E; Knutsen, Carsten; Klavina, Paula; Xie, Yike; Domingo-Gonzalez, Racquel; Liu, Min; Kum, Alexander; Jones, Robert C; Quake, Stephen R; Alvira, Cristina M; Cornfield, David N.
Afiliação
  • Zanini F; School of Clinical Medicine, University of New South Wales, Sydney, Australia. fabio.zanini@unsw.edu.au.
  • Che X; Cellular Genomics Futures Institute, University of New South Wales, Sydney, NSW, Australia. fabio.zanini@unsw.edu.au.
  • Suresh NE; Evolution & Ecology Research Centre, University of New South Wales, Sydney, NSW, Australia. fabio.zanini@unsw.edu.au.
  • Knutsen C; Center for Excellence in Pulmonary Biology, Stanford University School of Medicine, Stanford, CA, USA.
  • Klavina P; Division of Pulmonary, Asthma and Sleep Medicine, Department of Pediatrics, Stanford University School of Medicine, Stanford, CA, USA.
  • Xie Y; Center for Excellence in Pulmonary Biology, Stanford University School of Medicine, Stanford, CA, USA.
  • Domingo-Gonzalez R; Division of Pulmonary, Asthma and Sleep Medicine, Department of Pediatrics, Stanford University School of Medicine, Stanford, CA, USA.
  • Liu M; Center for Excellence in Pulmonary Biology, Stanford University School of Medicine, Stanford, CA, USA.
  • Kum A; Division of Critical Care Medicine, Department of Pediatrics, Stanford University School of Medicine, Stanford, CA, USA.
  • Jones RC; School of Biochemistry and Immunology, Trinity College Dublin, Dublin, Ireland.
  • Quake SR; School of Clinical Medicine, University of New South Wales, Sydney, Australia.
  • Alvira CM; Center for Excellence in Pulmonary Biology, Stanford University School of Medicine, Stanford, CA, USA.
  • Cornfield DN; Division of Critical Care Medicine, Department of Pediatrics, Stanford University School of Medicine, Stanford, CA, USA.
Sci Rep ; 14(1): 2033, 2024 01 23.
Article em En | MEDLINE | ID: mdl-38263350
ABSTRACT
Rapid expansion of the pulmonary microvasculature through angiogenesis drives alveolarization, the final stage of lung development that occurs postnatally and dramatically increases lung gas-exchange surface area. Disruption of pulmonary angiogenesis induces long-term structural and physiologic lung abnormalities, including bronchopulmonary dysplasia, a disease characterized by compromised alveolarization. Although endothelial cells are primary determinants of pulmonary angiogenesis, mesenchymal cells (MC) play a critical and dual role in angiogenesis and alveolarization. Therefore, we performed single cell transcriptomics and in-situ imaging of the developing lung to profile mesenchymal cells during alveolarization and in the context of lung injury. Specific mesenchymal cell subtypes were present at birth with increasing diversity during alveolarization even while expressing a distinct transcriptomic profile from more mature correlates. Hyperoxia arrested the transcriptomic progression of the MC, revealed differential cell subtype vulnerability with pericytes and myofibroblasts most affected, altered cell to cell communication, and led to the emergence of Acta1 expressing cells. These insights hold the promise of targeted treatment for neonatal lung disease, which remains a major cause of infant morbidity and mortality across the world.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Displasia Broncopulmonar / Hiperóxia / Células-Tronco Mesenquimais Limite: Humans / Infant / Newborn Idioma: En Revista: Sci Rep Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Austrália

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Displasia Broncopulmonar / Hiperóxia / Células-Tronco Mesenquimais Limite: Humans / Infant / Newborn Idioma: En Revista: Sci Rep Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Austrália